Evidence map›Paper›PMID 36810055›Full record

ArticleBMC complementary medicine and therapies2023

Antibacterial activity of oregano essential oils against Streptococcus mutans in vitro and analysis of active components.

Yue Yuan, Jinlong Sun, Yang Song, Rifat Nowshin Raka, Jie Xiang, Hua Wu, Junsong Xiao, Jianming Jin, XiuLi Hui

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Antimicrobial effects of essential oil fromFrontiers in cellular and infection microbiology · 2025
    Article
  14. Article
  15. Review
  16. Inhibition of the Biofilm Formation of PlantPharmaceuticals (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Review
  19. Hydroxypropyl Cellulose Hydrogel ContainingGels (Basel, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yue Yuan *Beijing Technology and Business University, Beijing, 100048, China.
Jinlong Sun *Department of Stomatology, Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.
Yang SongBeijing Technology and Business University, Beijing, 100048, China.
Rifat Nowshin RakaBeijing Technology and Business University, Beijing, 100048, China.
Jie XiangBeijing Technology and Business University, Beijing, 100048, China.
Hua WuBeijing Technology and Business University, Beijing, 100048, China. wuhua@btbu.edu.cn.
Junsong XiaoBeijing Technology and Business University, Beijing, 100048, China.
Jianming JinBeijing Technology and Business University, Beijing, 100048, China.
XiuLi HuiDepartment of Stomatology, Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.
Beijing Technology and Business University · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStreptococcus mutans (S. mutans) is considered the most relevant bacteria during the transition of the non-pathogenic commensal oral microbial community to plaque biofilms that promote the development of dental caries. Oregano (Origanum vulgare L.), is a universally natural flavoring and its essential oil has been demonstrated to have good antibacterial effects. However, the specific antibacterial mechanism of oregano essential oil (OEO) against S. mutans is still not completely understood.

methodsIn this work, the composition of two different OEOs was determined by GC‒MS. Disk-diffusion method, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined to assess their antimicrobial effect on S. mutans. The inhibition of acid production, hydrophobicity, biofilm formation and real-time PCR for gtfB/C/D, spaP, gbpB, vicR, relA and brpA mRNA expression by S. mutans were assessed to preliminarily investigate the mechanisms of action. Molecular docking was performed to simulate the interactions with the virulence proteins and active constituents. MTT test using immortalized human keratinocytes cells was also performed to investigate cytotoxicity.

resultsCompared with the positive drug Penicillin /streptomycin 100X (DIZ: 34.13 ± 0.85 mm, MIC: 0.78125 μL/mL, MBC: 6.25 μL/mL), the essential oils of Origanum vulgare L. (DIZ: 80 mm, MIC: 0.625μL/mL, MBC:2.5μL/mL) and Origanum heracleoticum L. (DIZ: 39.67 ± 0.81 mm, MIC: 0.625μL/mL, MBC: 1.25μL/mL) could also exhibit similar effects to inhibit the acid production and reduce the hydrophobicity and biofilm formation of S. mutans at 1/2-1MIC concentration. And gene expression of gtfB/C/D, spaP, gbpB, vicR and relA were found to be downregulated. Due to the composition of essential oils from different sources being highly variable, through effective network pharmacology analysis, we found that OEOs contained many effective compounds, like carvacrol and its biosynthetic precursors γ-terpinene and p-cymene, which may directly target several virulence proteins of S. mutans. Besides, no toxic effect was instigated by OEOs at 0.1 μL/mL in the immortalized human keratinocytes cells.

conclusionThe integrated analysis in the present study suggested that OEO might be a potential antibacterial agent for the prevention of dental caries.

Indexed as

Dental CariesOils, VolatileOriganumAnti-Bacterial AgentsHumansMolecular Docking SimulationStreptococcus mutansAnti-Bacterial AgentsOils, VolatileDental cariesGC–MSOregano essential oilStreptococcus mutans

Identifiers

PMID36810055
PMCPMC9942419
OpenAlexW4321459906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.